<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66-vaccines-07-00179">
 <label>66.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Long</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Doyle</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fernandez</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Klose</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sevvana</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bryan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Davidson</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Doranz</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Kuhn</surname>
    <given-names>R.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2019</year>
  <volume>116</volume>
  <fpage>1591</fpage>
  <lpage>1596</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1815432116</pub-id>
  <pub-id pub-id-type="pmid">30642974</pub-id>
 </element-citation>
</ref>
